August 28, 2025

FDA Requests Confirmatory Evidence on Wet AMD Therapy

Outlook Therapeutics’ drug for wet age-related macular degeneration faces an FDA approval setback.

Conexiant

August 21, 2025

FDA Grants RMAT to VeonGen Gene Therapy

VG801 is being developed for Stargardt disease and other ABCA4-related retinal disorders.

Retinal Physician

August 17, 2025

FDA Affirms Safety of PFAS-Based Materials in Medical Devices

PFAS used in medical devices are different from the small-molecule PFAS that have been linked to environmental and health concerns.

Contact Lens Spectrum

August 08, 2025

Alcon Acquisition

Alcon set to acquire STAAR surgical in $1.5B deal

The Ophthalmologist

July 08, 2025

Lenz Therapeutics Announces FDA Approval of Vizz for the Treatment of Presbyopia

Near vision improvements were demonstrated within 30 minutes and lasted up to 10 hours in clinical trials.

Ophthalmic Professional

November 15, 2024

Eyenovia Halts Eye Drug Trial

Eyenovia's late-stage study for near-sightedness in children with an experimental drug-device combination has been discontinued after failing to slow myopia progression, leading to consideration of strategic alternatives.

Reuters

April 24, 2025

FDA Rejects Extended Dosing Intervals for Eylea HD

The agency did not agree with Regeneron’s proposal to add dosing intervals greater than every 16 weeks, the maximum interval currently indicated for aflibercept 8 mg injections.

Retinal Physician

May 09, 2025

West Virginia Gains Scope of Practice Expansion

West Virginia passes a law enabling optometrists to use ophthalmic lasers, providing essential eye care services for patients, especially in rural areas, and increasing access for Medicare beneficiaries. Source: Optometric Management

Optometric Management

August 27, 2024

PCPs Play Important Role in Glaucoma Screening

“Recommendations from trusted primary providers have likely kept millions of individuals from becoming blind.”

Conexiant